These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11358453)

  • 21. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
    Lastres-Becker I; Molina-Holgado F; Ramos JA; Mechoulam R; Fernández-Ruiz J
    Neurobiol Dis; 2005; 19(1-2):96-107. PubMed ID: 15837565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
    Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing.
    Wright K; Rooney N; Feeney M; Tate J; Robertson D; Welham M; Ward S
    Gastroenterology; 2005 Aug; 129(2):437-53. PubMed ID: 16083701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.
    Calon F; Dridi M; Hornykiewicz O; Bédard PJ; Rajput AH; Di Paolo T
    Brain; 2004 May; 127(Pt 5):1075-84. PubMed ID: 15033896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins.
    Nilsson A; Sköld K; Sjögren B; Svensson M; Pierson J; Zhang X; Caprioli RM; Buijs J; Persson B; Svenningsson P; Andrén PE
    J Proteome Res; 2007 Oct; 6(10):3952-61. PubMed ID: 17877381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease.
    Lastres-Becker I; Fezza F; Cebeira M; Bisogno T; Ramos JA; Milone A; Fernández-Ruiz J; Di Marzo V
    Neuroreport; 2001 Jul; 12(10):2125-9. PubMed ID: 11447320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homeostatic changes of the endocannabinoid system in Parkinson's disease.
    Pisani V; Madeo G; Tassone A; Sciamanna G; Maccarrone M; Stanzione P; Pisani A
    Mov Disord; 2011 Feb; 26(2):216-22. PubMed ID: 21412829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical exercise in adolescence changes CB1 cannabinoid receptor expression in the rat brain.
    Gomes da Silva S; Araujo BH; Cossa AC; Scorza FA; Cavalheiro EA; Naffah-Mazzacoratti Mda G; Arida RM
    Neurochem Int; 2010 Nov; 57(5):492-6. PubMed ID: 20621146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice.
    Steiner H; Bonner TI; Zimmer AM; Kitai ST; Zimmer A
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5786-90. PubMed ID: 10318962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between the cannabinoid and dopaminergic systems: evidence from animal studies.
    El Khoury MA; Gorgievski V; Moutsimilli L; Giros B; Tzavara ET
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jul; 38(1):36-50. PubMed ID: 22300746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia.
    Julian MD; Martin AB; Cuellar B; Rodriguez De Fonseca F; Navarro M; Moratalla R; Garcia-Segura LM
    Neuroscience; 2003; 119(1):309-18. PubMed ID: 12763090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cannabinoid CB
    Rivas-Santisteban R; Lillo J; Raïch I; Muñoz A; Lillo A; Rodríguez-Pérez AI; Labandeira-García JL; Navarro G; Franco R
    Exp Neurol; 2023 Apr; 362():114319. PubMed ID: 36632949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia.
    Hallett PJ; Brotchie JM
    Mov Disord; 2007 Jan; 22(1):28-40. PubMed ID: 17089424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in mGlu5 receptor expression in the basal ganglia of reserpinised rats.
    Ismayilova N; Verkhratsky A; Dascombe MJ
    Eur J Pharmacol; 2006 Sep; 545(2-3):134-41. PubMed ID: 16890937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of repeated long-term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders.
    Tomas-Roig J; Piscitelli F; Gil V; Quintana E; Ramió-Torrentà LL; Del Río JA; Moore TP; Agbemenyah H; Salinas G; Pommerenke C; Lorenzen S; Beißbarth T; Hoyer-Fender S; Di Marzo V; Havemann-Reinecke U
    CNS Neurosci Ther; 2018 Jun; 24(6):528-538. PubMed ID: 29388323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the role of striatal cannabinoid CB1 receptors on movement activity of parkinsonian rats induced by reserpine.
    Moghaddam HF; Khodayar MJ; Abarghouei SM; Ardestani MS
    Saudi Pharm J; 2010 Oct; 18(4):207-15. PubMed ID: 23960729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat Brain.
    Kelly R; Bemelmans AP; Joséphine C; Brouillet E; McKernan DP; Dowd E
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical localization of the neural cannabinoid receptor in rat brain.
    Pettit DA; Harrison MP; Olson JM; Spencer RF; Cabral GA
    J Neurosci Res; 1998 Feb; 51(3):391-402. PubMed ID: 9486774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.